Enhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblasts

British Journal of Cancer

Volumn 104, Issue 3, 2011, Pages 505-513

  Shiirevnyamba, A ^a   Takahashi, T ^a   Shan, H ^a   Ogawa, H ^a   Yano, S ^b   Kanayama, H ^a   Izumi, K ^a   Uehara, H ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

bone metastasis; cell to cell interaction; osteoclastogenesis; physical contact; prostate cancer

Indexed keywords

BETA ACTIN; CADHERIN; CADHERIN ANTIBODY; CADHERIN II; COMPLEMENT COMPONENT C3; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METASTASIS; CANCER CELL; CELL CULTURE; CELL GROWTH; CELL INTERACTION; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; PROSTATE CANCER; UPREGULATION;

ANIMALS; ANTIGENS, CD; BONE RESORPTION; CADHERINS; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; HUMANS; MALE; MICE; MICE, NUDE; OSTEOBLASTS; OSTEOCLASTS; OSTEOLYSIS; PROSTATIC NEOPLASMS;

EID: 79551613962     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6606070     Document Type: Article

References (47)

1. Akatsu T, Takahashi N, Debari K, Morita I, Murota S, Nagata N, Takatani O, Suda T (1989) Prostaglandins promote osteoclastlike cell formation by a mechanism involving cyclic adenosine 30,50-monophosphate in mouse bone marrow cell cultures. J Bone Miner Res 4(1): 29-35
2. Bubendorf L, Schopfer A, Wagner U, Sauter G, Moch H, Willi N, Gasser TC, Mihatsch MJ (2000) Metastatic patterns of prostate cancer: an autopsy study of 1589 patients. Human Pathol 31(5): 578-583
3. Bussard KM, Gay CV, Mastro AM (2008) The bone microenvironment in metastasis; what is special about bone? Review. Cancer Metastasis Rev 27(1): 41-55
4. Charhon SA, Chapuy MC, Delvin EE, Valentin-Opran A, Edouard CM, Meunier PJ (1983) Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma special reference to osteomalacia. Cancer 51(5): 918-924
5. Cheng SL, Lecanda F, Davidson MK, Warlow PM, Zhang SF, Zhang L, Suzuki S, St John T, Civitelli R (1998) Human osteoblasts express a repertoire of cadherins, which are critical for BMP-2-induced osteogenic differentiation. J Bone Miner Res 13(4): 633-644
6. Cheville JC, Tindall D, Boelter C, Jenkins R, Lohse CM, Pankratz VS, Sebo TJ, Davis B, Blute ML (2002) Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival. Cancer 95(5): 1028-1036
7. Chu K, Cheng CJ, Ye X, Lee YC, Zurita AJ, Chen DT, Yu-Lee LY, Zhang S, Yeh ET, Hu MC, Logothetis CJ, Lin SH (2008) Cadherin-11 promotes the metastasis of prostate cancer cells to bone. Mol Cancer Res 6(8): 1259-1267
8. Chung TD, Yu JJ, Spiotto MT, Bartkowski M, Simons JW (1999) Characterization of the role of IL-6 in the progression of prostate cancer. Prostate 38(3): 199-207
9. Cowin P, Rowlands TM, Hatsell SJ (2005) Cadherins and catenins in breast cancer. Curr Opin Cell Biol 17(5): 499-508
10. Fizazi K, Yang J, Peleg S, Sikes CR, Kreimann EL, Daliani D, Olive M, Raymond KA, Janus TJ, Logothetis CJ, Karsenty G, Navone NM (2003) Prostate cancer cells-osteoblast interaction shifts expression of growth/ survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts. Clin Cancer Res 9(7): 2587-2597
11. Fujita T, Shiba H, Sakata M, Uchida Y, Nakamura S, Kurihara H (2002) SPARC stimulates the synthesis of OPG/OCIF, MMP-2 and DNA in human periodontal ligament cells. J Oral Pathol Med 31(6): 345-352
12. García-Moreno C, Méndez-Dávila C, de La Piedra C, Castro-Errecaborde NA, Traba ML (2002) Human prostatic carcinoma cells produce an increase in the synthesis of interleukin-6 by human osteoblasts. Prostate 50(4): 241-246.
13. Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA (2007) A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res 13(23): 7003-7011
14. Harris SA, Enger RJ, Riggs BL, Spelsberg TC (1995) Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res 10(2): 178-186
15. Hullinger TG, Taichman RS, Linseman DA, Somerman MJ (2000) Secretory products from PC-3 and MCF-7 tumor cell lines upregulate osteopontin in MC3T3-E1 cells. J Cell Biochem 78(4): 607-616
16. Jacob K, Webber M, Benayahu D, Kleinman HK (1999) Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone. Cancer Res 59(17): 4453-4457
17. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 2008. CA Cancer J Clin 58(2): 71-96
18. Kido J, Yamauchi N, Ohishi K, Kataoka M, Nishikawa S, Nakamura T, Kadono H, Ikedo D, Ueno A, Nonomura N, Okuyama A, Nagata T (1997) Inhibition of osteoblastic cell differentiation by conditioned medium derived from the human prostatic cancer cell line PC-3 in vitro. J Cell Biochem 67(2): 248-256
19. Kii I, Amizuka N, Shimomura J, Saga Y, Kudo A (2004) Cell-cell interaction mediated by cadherin-11 directly regulates the differentiation of mesenchymal cells into the cells of the osteo-lineage and the chondrolineage. J Bone Miner Res 19(11): 1840-1849
20. Lang SH, Miller WR, Habib FK (1995) Stimulation of human prostate cancer cell lines by factors present in human osteoblast-like cells but not in bone marrow. Prostate 27(5): 287-293
21. Liu XH, Kirschenbaum A, Yao S, Levine AC (2005) Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesi. Endocrinology 146(4): 1991-1998
22. Logothetis CJ, Lin SH (2005) Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer 5(1): 21-28
23. Mangham DC, Scoones DJ, Drayson MT (1993) Complement and the recruitment of mononuclear osteoclasts. J Clin Pathol 46(6): 517-521
24. Marie PJ (2002) Role of N-cadherin in bone formation. J Cell Physiol 190(3): 297-305
25. Martínez J, Silva S, Santibanez JF (1996) Prostate-derived soluble factors block osteoblast differentiation in culture. J Cell Biochem 61(1): 18-25
26. Mbalaviele G, Shin CS, Civitelli R (2006) Cell-cell adhesion and signaling through cadherins: connecting bone cells in their microenvironment. J Bone Miner Res 21(12): 1821-1827
27. Menter DG, Schilsky RL, DuBois RN (2010) Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward. Clin Cancer Res 16(5): 1384-1390
28. Michigami T, Shimizu N, Williams PJ, Niewolna M, Dallas SL, Mundy GR, Yoneda T (2000) Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity. Blood 96(5): 1953-1960
29. Morrissey C, Lai JS, Brown LG,Wang YC, Roudier MP, Coleman IM, Gulati R, Vakar-Lopez F, True LD, Corey E, Nelson PS, Vessella RL (2010) The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells. Prostate 70(4): 412-424
30. Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2(8): 584-593
31. Ohshiba T, Miyaura C, Ito A (2003) Role of prostaglandin E produced by osteoblasts in osteolysis due to bone metastasis. Biochem Biophys Res Commun 300(4): 957-964
32. Pishvaian MJ, Feltes CM, Thompson P, Bussemakers MJ, Schalken JA, Byers SW (1999) Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res 59(4): 947-952
33. Richardsen E, Uglehus RD, Due J, Busch C, Busund LT (2010) COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67. Cancer Epidemiol 34(3): 316-322
34. Roodman GD (2004) Mechanisms of bone metastasis. Review. N Engl J Med 350(16): 1655-1664
35. Roudier MP, True LD, Higano CS, Vesselle H, Ellis W, Lange P, Vessella RL (2003) Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone. Hum Pathol 34(7): 646-653
36. Said N, Frierson Jr HF, Chernauskas D, Conaway M, Motamed K, Theodorescu D (2009) The role of SPARC in the TRAMP model of prostate carcinogenesis and progression. Oncogene 28(39): 3487-3498
37. Sato T, Abe E, Jin CH, Hong MH, Katagiri T, Kinoshita T, Amizuka N, Ozawa H, Suda T (1993) The biological roles of the third component of complement in osteoclast formation. Endocrinology 133(1): 397-404
38. Siegsmund MJ, Yamazaki H, Pastan I (1994) Interleukin 6 receptor mRNA in prostate carcinomas and benign prostate hyperplasia. J Urol 151(5): 1396-1399
39. Sim HG, Cheng CW (2005) Changing demography of prostate cancer in Asia. Eur J Cancer 41(6): 834-845
40. Singh B, Berry JA, Shoher A, Ayers GD, Wei C, Lucci A (2007) COX-2 involvement in breast cancer metastasis to bone. Oncogene 26(26): 3789-3796
41. Takahashi T, Uehara H, Bando Y, Izumi K (2008) Soluble EP2 neutralizes prostaglandin E2-induced cell signaling and inhibits osteolytic tumor growth. Mol Cancer Ther 7(9): 2807-2816
42. Tomita K, van Bokhoven A, van Leenders GJ, Ruijter ET, Jansen CF, Bussemakers MJ, Schalken JA (2000) Cadherin switching in human prostate cancer progression. Cancer Res 60(13): 3650-3654
43. Trebec-Reynolds DP, Voronov I, Heersche JN, Manolson MF (2010) IL-1alpha and IL-1beta have different effects on formation and activity of large osteoclasts. J Cell Biochem 109(5): 975-982
44. Tsai CY, Lee TS, Kou YR, Wu YL (2009) Glucosamine inhibits IL-1betamediated IL-8 production in prostate cancer cells by MAPK attenuation. J Cell Biochem 108(2): 489-498
45. Uehara H, Kim SJ, Karashima T, Shepherd DL, Fan D, Tsan R, Killion JJ, Logothetis C, Mathew P, Fidler IJ (2003) Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases. J Natl Cancer Inst 95(6): 458-470
46. Wang J, Levenson AS, Satcher RL (2006) Identification of a unique set of genes altered during cell-cell contact in an in vitro model of prostate cancer bone metastasis. Int J Mol Med 17(5): 849-856
47. Yin JJ, Pollock CB, Kelly K (2005) Mechanisms of cancer metastasis to the bone. Cell Research 15(1): 57-62